These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28477733)

  • 61. The effects of oestrogens on linear bone growth.
    Juul A
    Hum Reprod Update; 2001; 7(3):303-13. PubMed ID: 11392377
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: a gender difference.
    Soares DV; Conceição FL; Brasil RR; Spina LD; Lobo PM; Silva EM; Buescu A; Vaisman M
    Growth Horm IGF Res; 2004 Dec; 14(6):436-41. PubMed ID: 15519251
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of GH replacement in young patients with childhood onset GH deficiency.
    Christiansen JS; Vahl N; Nørrelund H; Jørgensen JO
    Int J Clin Pract Suppl; 2002 May; (126):32-6. PubMed ID: 12090699
    [No Abstract]   [Full Text] [Related]  

  • 64. Selective modulation of sex steroids.
    Goldstein JS; Sites CK
    Ageing Res Rev; 2002 Feb; 1(1):17-28. PubMed ID: 12039446
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Seeking SOCS and sex steroids.
    Waters MJ
    Trends Endocrinol Metab; 2003; 14(4):149-51. PubMed ID: 12714271
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Managing Estrogen Therapy in the Pituitary Patient.
    Shoung N; Ho KKY
    J Endocr Soc; 2023 Mar; 7(5):bvad051. PubMed ID: 37143694
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gender and hormonal regulation of growth.
    Rogol AD
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1259-65. PubMed ID: 15506071
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
    Kam GY; Leung KC; Baxter RC; Ho KK
    J Clin Endocrinol Metab; 2000 May; 85(5):1918-22. PubMed ID: 10843175
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response.
    Florkowski CM; Barnard R; Livesey JH; Veveris T; Espiner EA; Donald RA
    Growth Horm IGF Res; 1999 Feb; 9(1):35-40. PubMed ID: 10207506
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults.
    Cook DM; Ludlam WH; Cook MB
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3956-60. PubMed ID: 10566634
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fracture incidence in GH-deficient patients on complete hormone replacement including GH.
    Holmer H; Svensson J; Rylander L; Johannsson G; Rosén T; Bengtsson BA; Thorén M; Höybye C; Degerblad M; Bramnert M; Hägg E; Engström BE; Ekman B; Thorngren KG; Hagmar L; Erfurth EM
    J Bone Miner Res; 2007 Dec; 22(12):1842-50. PubMed ID: 17725379
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas.
    Voltan G; Mazzeo P; Regazzo D; Scaroni C; Ceccato F
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373068
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vivo and in vitro regulation of pituitary transcription factor-1 (Pit-1) by changes in the hormone environment.
    González-Parra S; Chowen JA; García-Segura LM; Argente J
    Neuroendocrinology; 1996 Jan; 63(1):3-15. PubMed ID: 8839350
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Associated hormonal decline in aging: is there a role for GH therapy in aging men?
    Lombardi G; Di Somma C; Rota F; Colao A
    J Endocrinol Invest; 2005; 28(3 Suppl):99-108. PubMed ID: 16042367
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Bunderen CC; van den Dries CJ; Heymans MW; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Eur J Endocrinol; 2014 Aug; 171(2):151-60. PubMed ID: 24801587
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Regulation of growth hormone action by gonadal steroids.
    Meinhardt UJ; Ho KK
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):57-73. PubMed ID: 17336734
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy.
    Ragnar Agnarsson H; Johannsson G; Ragnarsson O
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1479-85. PubMed ID: 24423362
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM; Toogood AA; Tomlinson JW
    Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.